Amphastar Pharma (AMPH) reported Q4 EPS of $0.73, $0.33 better than the analyst estimate of $0.40. Revenue for the quarter came in at $135 million versus the consensus estimate of $127.25 million.
Amphastar Pharma (AMPH) reported Q4 EPS of $0.73, $0.33 better than the analyst estimate of $0.40. Revenue for the quarter came in at $135 million versus the consensus estimate of $127.25 million.